Cystic Fibrosis Foundation Celebrates FDA Approval of Orkambi as an Important Advance for the Cystic Fibrosis Community
FDA Grants Breakthrough Therapy Designation for Genzyme ’s Olipudase Alfa
Isis Pharmaceuticals to Present a General Corporate Update at its 2015 Annual Meeting of Stockholders and Open House
Alnylam Reports New Positive Clinical Data for ALN-AT3, a Subcutaneously Administered, Investigational RNAi Therapeutic Targeting Antithrombin (AT) for the Treatment of Hemophilia and Rare Bleeding Disorders
Global Genes to Host Fourth Annual Tribute to Champions of Hope Gala and Patient Advocacy Summit
A roundup of investment news.
Focusing on stocks with the most visible cash flows has been a winning strategy, and this screen can find them.
Who's in front heading 'round the bend?
Morningstar analysts see pharmaceuticals as 2010's hot zone for mergers and acquisitions.